메뉴 건너뛰기




Volumn 135, Issue , 2008, Pages 93-100

Complexation of statins with β-cyclodextrin in solutions of small molecular additives and macromolecular colloids

Author keywords

Cyclodextrins; Dissolution; Inclusion complexes; Macromolecular colloids; Statins; Supramolecular associates

Indexed keywords


EID: 62449282129     PISSN: 0340255X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/2882-2008-120     Document Type: Conference Paper
Times cited : (4)

References (26)
  • 1
    • 0023947965 scopus 로고
    • Pharmaceutical innovation by seven UK-owned pharmaceutical companies (1964-1985)
    • Prentis RA, Lis Y, Walker SR (1988) Pharmaceutical innovation by seven UK-owned pharmaceutical companies (1964-1985). Br J Clin Pharmacol 25:387-396
    • (1988) Br J Clin Pharmacol , vol.25 , pp. 387-396
    • Prentis, R.A.1    Lis, Y.2    Walker, S.R.3
  • 2
    • 0035843962 scopus 로고    scopus 로고
    • Structural mechanism for statin inhibition of HMG-CoA reductase
    • Istvan ES, Deisenhofer J (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292:1160-1164
    • (2001) Science , vol.292 , pp. 1160-1164
    • Istvan, E.S.1    Deisenhofer, J.2
  • 4
    • 1842609789 scopus 로고    scopus 로고
    • Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs
    • Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH (2004) Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 274:65-73
    • (2004) Int J Pharm , vol.274 , pp. 65-73
    • Kang, B.K.1    Lee, J.S.2    Chon, S.K.3    Jeong, S.Y.4    Yuk, S.H.5    Khang, G.6    Lee, H.B.7    Cho, S.H.8
  • 5
    • 0028146792 scopus 로고
    • Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: Two-year efficacy and safety follow-up
    • Bradford RH, Shear CL, Chremos AN, Dujovne CA, Franklin FA, Grillo RB et al. (1994) Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol 74:667-673
    • (1994) Am J Cardiol , vol.74 , pp. 667-673
    • Bradford, R.H.1    Shear, C.L.2    Chremos, A.N.3    Dujovne, C.A.4    Franklin, F.A.5    Grillo, R.B.6
  • 6
    • 0031034647 scopus 로고    scopus 로고
    • Pravastatin: A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease
    • Haria M, McTavish D (1997) Pravastatin: a reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease. Drugs 53:299-336
    • (1997) Drugs , vol.53 , pp. 299-336
    • Haria, M.1    McTavish, D.2
  • 7
    • 34548134519 scopus 로고    scopus 로고
    • Cyclodextrins as pharmaceutical solubilizers
    • ME Brewster, Loftsson T (2007) Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59:645-666
    • (2007) Adv Drug Deliv Rev , vol.59 , pp. 645-666
    • Brewster, M.E.1    Loftsson, T.2
  • 8
    • 0029819323 scopus 로고    scopus 로고
    • Loftsson T, Brewster M (1996) Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J Pharm Sci 85(10):1017-1025
    • Loftsson T, Brewster M (1996) Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J Pharm Sci 85(10):1017-1025
  • 9
    • 0038185084 scopus 로고    scopus 로고
    • The Driving Forces int he Inclusion Complexation of Cyclodextrins
    • Liu L, Guo QX (2002) The Driving Forces int he Inclusion Complexation of Cyclodextrins. J Incl Phenom Macrocycl Chem 42:1-14
    • (2002) J Incl Phenom Macrocycl Chem , vol.42 , pp. 1-14
    • Liu, L.1    Guo, Q.X.2
  • 13
    • 47149085403 scopus 로고    scopus 로고
    • Ciklodextrinek és sztatinok kölcsönhatásának in vitro vizsgálatai.
    • Süle A, Szente L, Csempesz F (2005) Ciklodextrinek és sztatinok kölcsönhatásának in vitro vizsgálatai. Acta Pharm Hung 75:9-13
    • (2005) Acta Pharm Hung , vol.75 , pp. 9-13
    • Süle, A.1    Szente, L.2    Csempesz, F.3
  • 14
    • 34248561935 scopus 로고    scopus 로고
    • Preparation and characterization of simvastatin/hydroxypropyl-b-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process
    • Jun SW, Kim M-S, Kim J-S, Park HJ, Lee S, Woo J-S, Hwang S-J (2007) Preparation and characterization of simvastatin/hydroxypropyl-b-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 66:413-417
    • (2007) Eur J Pharm Biopharm , vol.66 , pp. 413-417
    • Jun, S.W.1    Kim, M.-S.2    Kim, J.-S.3    Park, H.J.4    Lee, S.5    Woo, J.-S.6    Hwang, S.-J.7
  • 15
    • 62449083019 scopus 로고    scopus 로고
    • Physico-Chemical Characterization & In Vitro Dissolution Behavior of Simvastatin-Cyclodextrin Inclusion Compounds
    • Patel RP, Patel MM (2007) Physico-Chemical Characterization & In Vitro Dissolution Behavior of Simvastatin-Cyclodextrin Inclusion Compounds. Drug Deliv Technol 7(5):50-56
    • (2007) Drug Deliv Technol , vol.7 , Issue.5 , pp. 50-56
    • Patel, R.P.1    Patel, M.M.2
  • 17
    • 62449280289 scopus 로고    scopus 로고
    • European Directorate for the Quality of Medicines & HealthCare (EDQM) (ed) (2007) European Pharmacopeia 5th Edition 5.8 Supplement
    • European Directorate for the Quality of Medicines & HealthCare (EDQM) (ed) (2007) European Pharmacopeia 5th Edition 5.8 Supplement
  • 18
    • 0019368754 scopus 로고
    • New direct calculation of K1 : 1 and K1 : 2 complexation constants using solubility method
    • Iga K, Hussain A, Kashihara T (1981) New direct calculation of K1 : 1 and K1 : 2 complexation constants using solubility method. J Pharm Sci 70(1):108-109
    • (1981) J Pharm Sci , vol.70 , Issue.1 , pp. 108-109
    • Iga, K.1    Hussain, A.2    Kashihara, T.3
  • 19
    • 0034147761 scopus 로고    scopus 로고
    • Changes in the Solubility of β-Cyclodextrin on Complex Formation: Guest Enforced Solubility of β-Cyclodextrin Inclusion Complexes
    • Buvári-Barcza Á, Barcza L (2000) Changes in the Solubility of β-Cyclodextrin on Complex Formation: Guest Enforced Solubility of β-Cyclodextrin Inclusion Complexes. J Incl Phenom Macrocycl Chem 36:355-380
    • (2000) J Incl Phenom Macrocycl Chem , vol.36 , pp. 355-380
    • Buvári-Barcza, A.1    Barcza, L.2
  • 20
    • 0000740135 scopus 로고
    • Thin-layer chromatography with urea-solubilized β-cyclodextrin mobile phase
    • Hinze WL, Pharr DY, Fu ZS, Burkert WG (1989) Thin-layer chromatography with urea-solubilized β-cyclodextrin mobile phase. Anal Chem 61:422
    • (1989) Anal Chem , vol.61 , pp. 422
    • Hinze, W.L.1    Pharr, D.Y.2    Fu, Z.S.3    Burkert, W.G.4
  • 21
    • 62449298621 scopus 로고    scopus 로고
    • Süle A, Csempesz F (2005) Hatóanyag-oldékonyság szabályozása ciklodextrinekkel és kolloidokkal. Abst. Semmelweis Egyetem PhD Tudományos Napok, Budapest, Hungary, p 64
    • Süle A, Csempesz F (2005) Hatóanyag-oldékonyság szabályozása ciklodextrinekkel és kolloidokkal. Abst. Semmelweis Egyetem PhD Tudományos Napok, Budapest, Hungary, p 64
  • 24
    • 0031991929 scopus 로고    scopus 로고
    • Effects of Some Hydrotropic Agents on the Formation of Indomethacin/β-Cyclodextrin Inclusion Compounds
    • Pioger E, Wouessidjewe D, Douchene D, Bogdanova S (1998) Effects of Some Hydrotropic Agents on the Formation of Indomethacin/β-Cyclodextrin Inclusion Compounds. J Incl Phenom Macrocycl Chem 30:151-161
    • (1998) J Incl Phenom Macrocycl Chem , vol.30 , pp. 151-161
    • Pioger, E.1    Wouessidjewe, D.2    Douchene, D.3    Bogdanova, S.4
  • 26
    • 33744501734 scopus 로고    scopus 로고
    • Cyclodextrins as second-sphere ligand for transition metal complexes
    • Stoddart FJ, Zarzycki R (1998) Cyclodextrins as second-sphere ligand for transition metal complexes. Rec Trav Chim Pays-Bas 107:515-528
    • (1998) Rec Trav Chim Pays-Bas , vol.107 , pp. 515-528
    • Stoddart, F.J.1    Zarzycki, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.